Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-01
DOI
10.3389/fimmu.2018.00932
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein–Barr Virus, but Not Cytomegalovirus, Latency Accelerates the Decay of Childhood Measles and Rubella Vaccine Responses—A 10-Year Follow-up of a Swedish Birth Cohort
- (2017) Gintare Lasaviciute et al. Frontiers in Immunology
- Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
- (2017) Hongyan Liu et al. Frontiers in Immunology
- Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus
- (2016) MOLECULES AND CELLS
- Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
- (2016) Xinle Cui et al. VACCINE
- Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
- (2016) Elizabeth M. Perez et al. Oncotarget
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
- (2015) Javier Ogembo et al. Journal of Translational Medicine
- A Novel ICOS-Independent, but CD28- and SAP-Dependent, Pathway of T Cell-Dependent, Polysaccharide-Specific Humoral Immunity in Response to Intact Streptococcus pneumoniae versus Pneumococcal Conjugate Vaccine
- (2014) Q. Chen et al. JOURNAL OF IMMUNOLOGY
- The role of Epstein-Barr virus in epithelial malignancies
- (2014) Sai-Wah Tsao et al. JOURNAL OF PATHOLOGY
- Repertoire of Epitopes Recognized by Serum IgG from Humans Vaccinated with Herpes Simplex Virus 2 Glycoprotein D
- (2014) J. Charles Whitbeck et al. JOURNAL OF VIROLOGY
- Dissection of the Antibody Response against Herpes Simplex Virus Glycoproteins in Naturally Infected Humans
- (2014) T. M. Cairns et al. JOURNAL OF VIROLOGY
- Progress, prospects, and problems in Epstein-Barr virus vaccine development
- (2014) Henry H Balfour Current Opinion in Virology
- Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010
- (2014) Gulfaraz Khan et al. Infectious Agents and Cancer
- A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine
- (2013) Xinle Cui et al. VACCINE
- Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
- (2013) Javier G. Ogembo et al. Cell Reports
- Fc-fusion proteins: new developments and future perspectives
- (2012) Daniel M. Czajkowsky et al. EMBO Molecular Medicine
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- Efficient mucosal vaccination mediated by the neonatal Fc receptor
- (2011) Lilin Ye et al. NATURE BIOTECHNOLOGY
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
- Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice
- (2011) Krishnamurthy Konduru et al. VACCINE
- Polymeric human Fc-fusion proteins with modified effector functions
- (2011) David N. A. Mekhaiel et al. Scientific Reports
- On the Role of Aggregates in the Immunogenicity of Recombinant Human Interferon Beta in Patients with Multiple Sclerosis
- (2010) Miranda M.C. van Beers et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
- (2009) Lesley Rees et al. TRANSPLANTATION
- Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay
- (2009) Junji Sashihara et al. VIROLOGY
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Optimal treatment for chronic active Epstein-Barr virus disease
- (2008) Jeffrey I. Cohen PEDIATRIC TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now